Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Seattle Genetics Inc (NASDAQ:SGEN)

46.90
BATS BZX Real-Time Price
As of 10:25am ET
 +0.32 / +0.69%
Today’s Change
30.05
Today|||52-Week Range
52.33
+45.97%
Year-to-Date

Today’s Trading

Previous close46.58
Today’s open46.30
Day’s range45.68 - 46.89
Volume94,596
Average volume (3 months)977,339
Market cap$5.8B
Dividend yield--
Data as of 10:12am ET, 08/04/2015

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)-54.11%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+6.50%
P/E ratioNM
Price/Sales13.83
Price/Book27.39

Competitors

 Today’s
change
Today’s
% change
TAROTaro Pharmaceutical ...+0.99+0.70%
HZNPHorizon Pharma PLC-0.48-1.36%
ICPTIntercept Pharmaceut...+1.66+0.64%
ANACAnacor Pharmaceutica...+5.83+3.91%
Data as of 10:27am ET, 08/04/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$286.8M
Annual profit (last year)-$76.1M
Net profit margin-26.55%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts